Encoder Products Company (EPC), a U.S.-based designer and manufacturer of motion feedback devices, announces the launch of the LP1 Accu-LaserPro, a breakthrough non-contact encoder designed for ...
Encoder Products Company (EPC), a designer and manufacturer of motion feedback devices, has announced the release of a new line of IO-Link enabled encoders. Built to deliver seamless integration with ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults ...
AstraZeneca ( NASDAQ: AZN) and Daiichi Sankyo have received priority review from the FDA for their supplemental marketing application for Enhertu in combination with pertuzumab, marketed by Roche ( ...
Patients on Enhertu and Perjeta lived more than three years without disease progression compared to just over two years on Perjeta, Herceptin, and chemo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback